| Rituximab for Anti-cytokine Autoantibody-Associated Diseases (NCT01842386) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-04-29 |
| Effects of Intranasal Oxytocin on Emotion Regulation in Adolescents (NCT02301715) | Centre Hospitalier Universitaire de Besancon | 2014-04-29 |
| Trametinib With or Without Whole Brain Radiation Therapy in Treating Patients With Brain Metastases (NCT02015117) | National Cancer Institute (NCI) | 2014-04-28 |
| Pharmacokinetic Study of Lidocaine Patch 1.8% Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects (NCT04144192) | Scilex Pharmaceuticals, Inc. | 2014-04-28 |
| Single-Dose Bioavailability Study of Two Formulations of Ibuprofen and Pseudoephedrine Hydrochloride Tablets (NCT03429738) | Institut für Pharmakologie und Präventive Medizin | 2014-04-27 |
| Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1 (NCT02124083) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2014-04-25 |
| MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer (NCT02068794) | Mayo Clinic | 2014-04-25 |
| Carfilzomib, Bendamustine Hydrochloride, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT02095834) | M.D. Anderson Cancer Center | 2014-04-24 |
| A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK2816126 in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma, Transformed Follicular Lymphoma, Other Non-Hodgkin's Lymphomas, Solid Tumors and Multiple Myeloma (NCT02082977) | GlaxoSmithKline | 2014-04-24 |
| A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL (NCT02081378) | Novartis Pharmaceuticals | 2014-04-24 |
| Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin (NCT02029690) | Polaris Group | 2014-04-23 |
| Effects of an Immunosuppressant Mycophenolate Mofetil or MMF on the Urinary Sodium Excretion Response to Mental Stress (NCT02432339) | Augusta University | 2014-04-22 |
| A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Anti-Cancer Activity of Trametinib in Combination With Palbociclib in Subjects With Solid Tumors (NCT02065063) | GlaxoSmithKline | 2014-04-22 |
| Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia (NCT01904136) | M.D. Anderson Cancer Center | 2014-04-22 |
| Effect of Regorafenib on Digoxin and Rosuvastatin in Patients With Advanced Solid Malignant Tumors. (NCT02106845) | Bayer | 2014-04-22 |
| A Study of the Safety and Pharmacokinetics of RO6839921, An MDM2 Antagonist, in Patients With Advanced Cancers, Including Acute Myeloid Leukemia. (NCT02098967) | Hoffmann-La Roche | 2014-04-21 |
| Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer (NCT02121990) | Memorial Sloan Kettering Cancer Center | 2014-04-21 |
| Safety Study of a Capsule-Conjugate Vaccine to Prevent Campylobacter-Caused Diarrhea (NCT02067676) | U.S. Army Medical Research and Development Command | 2014-04-21 |
| Natural Compounds to Reduce Nitrite in Meat Products (NCT04138654) | Maastricht University | 2014-04-17 |
| A Relative Bioavailability Study of a Fixed Dose Combination (FDC) Tablets of GSK587323 (NCT02094924) | GlaxoSmithKline | 2014-04-17 |
| Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma (NCT01959698) | Roswell Park Cancer Institute | 2014-04-17 |
| Study to Evaluate Fractional Collagen Synthesis Within Keloid Scars and Identify Biomarkers of Keloid Scars (NCT01978301) | GlaxoSmithKline | 2014-04-15 |
| Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas (NCT02120807) | Memorial Sloan Kettering Cancer Center | 2014-04-15 |
| A Phase 1/2 Study Evaluating AMG 337 in Asian Subjects (NCT02096666) | Amgen | 2014-04-15 |
| Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT02035527) | Ohio State University Comprehensive Cancer Center | 2014-04-14 |
| SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC) (NCT01966289) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-04-14 |
| A Study Evaluating the Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 in Healthy Subjects. (NCT04033939) | Sichuan Haisco Pharmaceutical Group Co., Ltd | 2014-04-13 |
| A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard Therapy (NCT02085148) | Bayer | 2014-04-11 |
| A Study To Evaluate The Effect Of Food On The Behavior Of Tofacitinib Modified Release 11 Milligram Tablets In Healthy Western And Japanese Volunteers (NCT02084875) | Pfizer | 2014-04-11 |
| A Study Of PF-06647263 In Patients With Advanced Solid Tumors (NCT02078752) | Pfizer | 2014-04-09 |
| Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer (NCT02009332) | Aadi Bioscience, Inc. | 2014-04-09 |
| A Dose Escalation Study of ASP8273 in Subjects With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations (NCT02113813) | Astellas Pharma Global Development, Inc. | 2014-04-09 |
| HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer Post Neoadjuvant Chemotherapy (NCT02061423) | H. Lee Moffitt Cancer Center and Research Institute | 2014-04-08 |
| Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer (NCT01918644) | University of Wisconsin, Madison | 2014-04-08 |
| Metformin and Muscle in Insulin-resistant Older Veterans (NCT01804049) | VA Office of Research and Development | 2014-04-08 |
| A Study of ALXN1840 (Coated and Non-coated) Administered With And Without Omeprazole In Healthy Adults (NCT05319912) | Alexion Pharmaceuticals, Inc. | 2014-04-07 |
| A Phase 1/2 Study of Repeated Intravenous E6011 Administration in Japanese Subjects With Crohn's Disease (NCT02039063) | EA Pharma Co., Ltd. | 2014-04-05 |
| Effect of Vorinostat on Nervous System Hemangioblastomas in Von Hippel-Lindau Disease (Missense Mutation Only) (NCT02108002) | National Institute of Neurological Disorders and Stroke (NINDS) | 2014-04-05 |
| A Phase 1b Study of Atezolizumab in Combination With Erlotinib or Alectinib in Participants With Non-Small Cell Lung Cancer (NSCLC) (NCT02013219) | Hoffmann-La Roche | 2014-04-03 |
| Vemurafenib Plus Cobimetinib Plus PEG-interferon in Advanced Melanoma Patients Harboring the V600BRAF Mutation (NCT01959633) | Fondazione Melanoma Onlus | 2014-04-03 |
| Targeted Silica Nanoparticles for Real-Time Image-Guided Intraoperative Mapping of Nodal Metastases (NCT02106598) | Memorial Sloan Kettering Cancer Center | 2014-04-03 |
| A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics (NCT01915277) | Carelon Research | 2014-04-02 |
| Auranofin PK Following Oral Dose Administration (NCT02089048) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-04-02 |
| Retapamulin Microdialysis Feasibility Study (NCT01812382) | GlaxoSmithKline | 2014-04-02 |
| ACY-1215 for Relapsed/Refractory Lymphoid Malignancies (NCT02091063) | Jennifer Amengual | 2014-04-02 |
| Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer (NCT02023463) | Thomas Jefferson University | 2014-04-02 |
| Dacomitinib Plus PD-0325901 in Advanced KRAS Mutant NSCLC (NCT02039336) | The Netherlands Cancer Institute | 2014-04-02 |
| Natural Killer Cells in Acute Leukaemia and Myelodysplastic Syndrome (NCT02123836) | National University Hospital, Singapore | 2014-04-01 |
| Ruxolitinib in the Treatment of Chronic Lymphocytic Leukemia (NCT02015208) | Sunnybrook Health Sciences Centre | 2014-04-01 |
| Absolute Bioavailability of BMS-791325 (NCT02112110) | Bristol-Myers Squibb | 2014-04-01 |
| Pharmacokinetic Study of Lurasidone After Multiple Oral Administration in Healthy Human Subjects (NCT02174523) | Marubeni Pharmaceuticals (Suzhou) Co., Ltd. | 2014-04-01 |
| PK and PD of Single, Escalating Doses of PER977 Following Enoxaparin (NCT02206100) | Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. | 2014-04-01 |
| A 2-Part Study to Evaluate the Safety of Supra-Therapeutic Doses of RO4602522 and to Investigate the Effect of RO4602522 on the QTc Interval (NCT02104648) | Hoffmann-La Roche | 2014-04-01 |
| Gene Therapy for Netherton Syndrome (NCT01545323) | Great Ormond Street Hospital for Children NHS Foundation Trust | 2014-04-01 |
| Image Guided Treatment Optimization With Cetuximab for Patients With Metastatic Colorectal Cancer (NCT02117466) | Amsterdam UMC, location VUmc | 2014-04-01 |
| Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Patients With Multiple Sclerosis (NCT01933802) | Tisch Multiple Sclerosis Research Center of New York | 2014-04-01 |
| A Study of LY2835219 in Participants With Cancer (NCT02117648) | Eli Lilly and Company | 2014-04-01 |
| Tenofovir Levels Following Local Application of Tenofovir Reduced-Glycerin 1% Gel (NCT01768962) | CONRAD | 2014-04-01 |
| Study Of Three Different Stomach Acid Reducing Agents When Given With Palbociclib (PD-0332991) And Food (NCT02097329) | Pfizer | 2014-04-01 |
| Pharmacokinetics And Relative Bioavailability Of Bococizumab (PF-04950615; RN316) When Administered To The Abdomen, Thigh Or Upper Arm (NCT02043301) | Pfizer | 2014-04-01 |
| Dose Escalation, Randomized Controlled Trial to Evaluate the Safety, Immunogenicity and Efficacy of Intravenously Administered Attenuated Plasmodium Falciparum Sporozoite Vaccine (PfSPZ Vaccine) in Tanzanian Adults (NCT02132299) | Sanaria Inc. | 2014-04-01 |
| Comparative Evaluation of Pharmacokinetics After CKD-501 Between Renal Impaired and Normal Renal Function Subjects (NCT02007941) | Chong Kun Dang Pharmaceutical | 2014-04-01 |
| A Study to Assess the Safety and Tolerability, Including Gastrointestinal Safety, Pharmacokinetics and Pharmacodynamics of ASP7657 in Caucasian Healthy Male and Female Subjects (NCT02108548) | Astellas Pharma Europe B.V. | 2014-04-01 |
| Phase 1 Safety Study of ALK-001 in Healthy Volunteers (NCT02230228) | Alkeus Pharmaceuticals, Inc. | 2014-04-01 |
| Study to Evaluate the PK, Relative Bioavailability and Safety of TG-2349 With Single Oral Dose Under Fed Condition in Healthy Volunteers (NCT02108418) | TaiGen Biotechnology Co., Ltd. | 2014-04-01 |
| Trial of Adoptive Immunotherapy With TRACT to Prevent Rejection in Living Donor Kidney Transplant Recipients (NCT02145325) | Northwestern University | 2014-04-01 |
| Combination Study of Urelumab and Cetuximab in Patients With Advanced/Metastatic Colorectal Cancer or Advanced/Metastatic Head and Neck Cancer (NCT02110082) | Bristol-Myers Squibb | 2014-04-01 |
| Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma (NCT02110563) | Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | 2014-04-01 |
| A Thorough QT/QTc Study to Assess the Effects of Androxal in Healthy Male Subjects (NCT02117830) | Repros Therapeutics Inc. | 2014-04-01 |
| Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia (NCT02154503) | Vancouver General Hospital | 2014-04-01 |
| Combined Rg3-enriched Korean Red Ginseng and American Ginseng in the Management of Hypertension in Type 2 Diabetes (NCT01578837) | Unity Health Toronto | 2014-04-01 |
| Bioequivalence Study of Telmisartan Between T80/A5/H12.5 mg FDC Tablet and T80/A5 mg Tab and H12.5 mg Tab Concomitant Use (NCT02121535) | Boehringer Ingelheim | 2014-04-01 |
| Cystatin-C C-guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project (NCT02945241) | Mayo Clinic | 2014-04-01 |
| Treatment of Negative Symptoms and Schizophrenia (NCT02204787) | University Hospital, Montpellier | 2014-04-01 |
| A Study to Assess the Effect of Rifampin on the Metabolism of ABT-199 (NCT01969682) | AbbVie | 2014-04-01 |
| A Randomized, Phase I, Cross-Over Study to Assess the Relative Bioavailability of Single-Dose Cobimetinib (GDC-0973) in Tablet vs. Capsule Formulation (NCT02136524) | Genentech, Inc. | 2014-04-01 |
| Hyperbaric Oxygen Therapy Can Improve Neurological State Post Meningioma Removal Surgery (NCT02084927) | Assaf-Harofeh Medical Center | 2014-04-01 |
| Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivikar Tab. 5/40 mg in Healthy Adult Male Subjects (NCT02955498) | Hanlim Pharm. Co., Ltd. | 2014-04-01 |
| Safety Study to Assess AFM11 in Patients With Relapsed and/or Refractory CD19 Positive B-cell NHL (NCT02106091) | Affimed GmbH | 2014-04-01 |
| iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma (NCT01953900) | Baylor College of Medicine | 2014-04-01 |
| Phase I Study on VEGF Vaccination in Metastatic Solid Tumors (NCT02237638) | Amsterdam UMC, location VUmc | 2014-04-01 |
| Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of K-312 in Healthy Subjects (NCT02676596) | Kowa Research Institute, Inc. | 2014-04-01 |
| Phase I/II - Brentuximab/5-Azacytidine in Acute Myeloid Leukemia (AML) (NCT02096042) | M.D. Anderson Cancer Center | 2014-04-01 |
| A Study of the Effect of Formulation and Tablet Hardness on the Bioavailability of Pictilisib in Healthy Volunteers (NCT02092831) | Genentech, Inc. | 2014-04-01 |
| To Assess Safety, Tolerability and Pharmacokinetics of BI 416970 in Healthy Male Volunteers (NCT02093819) | Boehringer Ingelheim | 2014-04-01 |
| VEGF-targeted Fluorescence Near-Infrared (NIR) Endoscopy in (Pre)Malignant Esophageal Lesions (NCT02129933) | University Medical Center Groningen | 2014-04-01 |
| Melatonin Treatment for Newborn Infants With Moderate to Severe Hypoxic Ischemic Encephalopathy (NCT01904786) | St. Louis University | 2014-04-01 |
| Neoadjuvant FIRINOX for Borderline Resectable Pancreatic Cancer - a Pilot Study (NCT02148549) | Wakayama Medical University | 2014-04-01 |
| Acute Effect of Pomegranate Extract on Cognitive Function (NCT02935777) | Angela Stockton | 2014-04-01 |
| Phase I Trial of LDE225 for Steroid-refractory Chronic GVHD After Allogeneic HSCT (NCT02086513) | Massachusetts General Hospital | 2014-04-01 |
| A Pre-surgical Study of LDE225 in Men With High-risk Localized Prostate Cancer (NCT02111187) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-04-01 |
| Drug Interaction Study of an OCP (Norethindrone (ND) Acetate and Ethinyl Estradiol (EE))With a Combination of Daclatasvir (DCV) Asunaprevir (ASV) and BMS-791325 (NCT02103569) | Bristol-Myers Squibb | 2014-04-01 |
| Daily-life Brain Control Of A Hand Exoskeleton After Cervical Spinal Cord Injury (NCT02336321) | University Hospital Tuebingen | 2014-04-01 |
| Atomoxetine's Effects On Nicotine Response And Stress Response In Smokers (NCT02046551) | Yale University | 2014-04-01 |
| Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer (NCT01938833) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2014-04-01 |
| A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients (NCT02403440) | Jiangsu HengRui Medicine Co., Ltd. | 2014-04-01 |
| Florbetapir Calibration to the Centiloid Scale (NCT02120664) | Avid Radiopharmaceuticals | 2014-04-01 |
| The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults (NCT02057263) | Massachusetts General Hospital | 2014-04-01 |
| Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne Vulgaris (NCT02929719) | Sun Pharmaceutical Industries, Inc. | 2014-04-01 |
| Study to Evaluate the Effect of Food on the Pharmacokinetics of Surfolase CR Tablet in Healthy Volunteers (NCT02373891) | Hyundai Pharmaceutical Co., LTD. | 2014-04-01 |